Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody
- 作者Michael N. Needle
- 卷第29卷
- 印刷ISSN0093-7754
- 文件大小140.95KB
- 发表时间2002
- DOI10.1016/s0093-7754(02)70091-2
- 页码55-60
Chemotherapy of multiple myelomaBrian G.M. Durie · 1991
Treatment of Myeloma — Are We Making Progress?Durie, Brian G.M. · New England Journal of Medicine · 2008
Primary amyloidosis associated with multiple myeloma. Predictors of successful therapyKathleen Fielder; Brian G.M. Durie · 1986
Immunofluorescence Method Improves Clinical Utility of Myeloma Cell Labeling IndicesDurie, Brian G.M. · Mayo Clinic Proceedings · 1987
Immunoquantitation of free light chain immunoglobulins: Applications in multiple myelomaPerry W. Cole; Brian G.M. Durie; Sydney E. Salmon · 1978
Cellular and Molecular Genetic Features of Myeloma and Related DisordersDurie, Brian G.M. · Hematology/Oncology Clinics of North America · 1992
Use of Bisphosphonates in Multiple Myeloma: IMWG Response to Mayo Clinic Consensus StatementDurie, Brian G.M. · 2007